Publicaciones en las que colabora con Joseba Bidaurrazaga (17)

2021

  1. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

    Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645

2020

  1. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study

    European Journal of Surgical Oncology, Vol. 46, Núm. 6, pp. 1151-1159

2018

  1. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 201-211

2017

  1. Cancer incidence in Spain, 2015

    Clinical and Translational Oncology, Vol. 19, Núm. 7, pp. 799-825

  2. Data quality in rare cancers registraton: The report of the RARECARE data quality study

    Tumori, Vol. 103, Núm. 1, pp. 22-32

  3. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  4. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  5. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

  6. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

    European Journal of Cancer, Vol. 77, pp. 140-152

  7. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413

  8. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404

  9. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

    The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217

2015

  1. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    The Lancet, Vol. 385, Núm. 9972, pp. 977-1010

  2. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2144-2157

  3. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2169-2178

2014

  1. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study

    The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34

  2. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

    Cancer Epidemiology, Vol. 38, Núm. 6, pp. 670-678